Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06610019 · ClinicalTrials.gov registry record
Cardiovascular Multimodality Imaging Study
A clinical trial of Heart Failure and Sarcoidosis, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT06610019: Recruiting study of Heart Failure and Sarcoidosis, sponsored by Montefiore Medical Center.
NCT06610019 is a study of Heart Failure and Sarcoidosis that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 5,000 participants, above the 2,036-participant average among 397 other Heart Failure trials with a reported enrollment target (146% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06610019, a study of Heart Failure and Sarcoidosis, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Determining the etiology of cardiomyopathy is of high clinical importance for optimal treatment strategy and prediction of prognosis. There is increased risk for cardiovascular disease and higher propensity for cardiovascular related mortality among Black and non-Hispanic White patients. Recently, advanced cardiac imaging has become a vital tool in diagnosis and risk stratification of cardiovascular disease. Very limited data is available on the prevalence and characteristics of different cardiovascular diseases in Hispanic and African American minority groups, therefore, studying different racial and ethnic minority groups in the Bronx population is an exceptionally valuable source to determine the prevalence of cardiomyopathies among minority groups along with study survival in this population. This study aims to determine the etiology of cardiovascular disease in a diverse patient population by utilizing various cardiovascular imaging modalities, with a focus on cardiac magnetic resonance (CMR) imaging and to develop risk stratification models by applying advanced cardiovascular imaging markers.
Primary Outcome
The number of patients who died from any cause will be summarized and reported using basic descriptive statistics.
Conditions Studied
Study Locations (1)
New York
- Montefiore Health System - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2031-12 |
What NCT06610019 shows while recruiting
NCT06610019 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,036-participant average among 397 other Heart Failure trials with a reported enrollment target (146% higher).
The record links to 10 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT06610019 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06610019 about?
NCT06610019 is a clinical study titled "Cardiovascular Multimodality Imaging Study". Determining the etiology of cardiomyopathy is of high clinical importance for optimal treatment strategy and prediction of prognosis. There is increased risk for cardiovascular disease and higher propensity for cardiovascular related mortality among Black and non-Hispanic White patients. Recently, a...
What is the current status of trial NCT06610019?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2023-05-01. Estimated completion is 2031-12.
What conditions does trial NCT06610019 study?
This clinical trial studies the following conditions: Heart Failure, Sarcoidosis, Cardiomyopathies, Hypertrophic Cardiomyopathy, Cardiac Amyloidosis.
Who is sponsoring clinical trial NCT06610019?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06610019 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06610019's enrollment target sits among peer trials
5,000 19th of 397 higher than 374 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI